185 related articles for article (PubMed ID: 8570727)
41. Photodynamic therapy with Pd-Bacteriopheophorbide (TOOKAD): successful in vivo treatment of human prostatic small cell carcinoma xenografts.
Koudinova NV; Pinthus JH; Brandis A; Brenner O; Bendel P; Ramon J; Eshhar Z; Scherz A; Salomon Y
Int J Cancer; 2003 May; 104(6):782-9. PubMed ID: 12640688
[TBL] [Abstract][Full Text] [Related]
42. Photodynamic therapy in the canine prostate using motexafin lutetium.
Hsi RA; Kapatkin A; Strandberg J; Zhu T; Vulcan T; Solonenko M; Rodriguez C; Chang J; Saunders M; Mason N; Hahn S
Clin Cancer Res; 2001 Mar; 7(3):651-60. PubMed ID: 11297261
[TBL] [Abstract][Full Text] [Related]
43. G-Quadruplex/Porphyrin Composite Photosensitizer: A Facile Way to Promote Absorption Redshift and Photodynamic Therapy Efficacy.
Cheng M; Cui YX; Wang J; Zhang J; Zhu LN; Kong DM
ACS Appl Mater Interfaces; 2019 Apr; 11(14):13158-13167. PubMed ID: 30901194
[TBL] [Abstract][Full Text] [Related]
44. Integrating sphere effect in whole-bladder wall photodynamic therapy: III. Fluence multiplication, optical penetration and light distribution with an eccentric source for human bladder optical properties.
van Staveren HJ; Keijzer M; Keesmaat T; Jansen H; Kirkel WJ; Beek JF; Star WM
Phys Med Biol; 1996 Apr; 41(4):579-90. PubMed ID: 8730658
[TBL] [Abstract][Full Text] [Related]
45. Excitation of a Single Compound by Light and Ultrasound Enhanced the Long-Term Cure of Mice Bearing Prostate Tumors.
Cacaccio J; Durrani FA; Kumar I; Dukh M; Camacho S; Fayazi Z; Sumlin A; Kauffman E; Guru K; Pandey RK
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445799
[TBL] [Abstract][Full Text] [Related]
46. Purpurins and benzochlorins as sensitizers for photodynamic therapy.
Garbo GM
J Photochem Photobiol B; 1996 Jul; 34(2-3):109-16. PubMed ID: 8810528
[TBL] [Abstract][Full Text] [Related]
47. Short-Wavelength Aggregation-Induced Emission Photosensitizers for Solid Tumor Therapy: Enhanced with White-Light Fiber Optic.
Meng Z; Chen Z; Lu G; Dong X; Dai J; Lou X; Xia F
Int J Nanomedicine; 2022; 17():6607-6619. PubMed ID: 36578442
[TBL] [Abstract][Full Text] [Related]
48. Influence of laser wavelength on the damage of comb's vasculature by photodynamic therapy--simulation and validation of mathematical models.
Huang N; Cheng G; Wang Y; Zeng J; Qiu H; Gu Y
Lasers Med Sci; 2011 Sep; 26(5):665-72. PubMed ID: 21327444
[TBL] [Abstract][Full Text] [Related]
49. Photodynamic therapy in 2D and 3D human cervical carcinoma cell cultures employing LED light sources emitting at different wavelengths.
Etcheverry ME; Pasquale MA; Bergna C; Ponzinibbio C; Garavaglia M
Phys Med Biol; 2020 Jan; 65(1):015017. PubMed ID: 31739296
[TBL] [Abstract][Full Text] [Related]
50. Nano-enabled SERS reporting photosensitizers.
Farhadi A; Roxin Á; Wilson BC; Zheng G
Theranostics; 2015; 5(5):469-76. PubMed ID: 25767614
[TBL] [Abstract][Full Text] [Related]
51. Luminol as in situ light source in meso-tetraphenylporphyrin-mediated photodynamic therapy.
Huang L; Chen TC; Lin FH
Curr Med Chem; 2013; 20(9):1195-202. PubMed ID: 23298136
[TBL] [Abstract][Full Text] [Related]
52. Interstitial photodynamic therapy of the canine prostate using intra-arterial administration of photosensitizer and computerized pulsed light delivery.
Xiao Z; Dickey D; Owen RJ; Tulip J; Moore R
J Urol; 2007 Jul; 178(1):308-13. PubMed ID: 17499802
[TBL] [Abstract][Full Text] [Related]
53. The application of photodynamic therapy in the head and neck.
Jerjes W; Upile T; Betz CS; El Maaytah M; Abbas S; Wright A; Hopper C
Dent Update; 2007 Oct; 34(8):478-80, 483-4, 486. PubMed ID: 18019486
[TBL] [Abstract][Full Text] [Related]
54. Photodynamic therapy in the management of metastatic cutaneous adenocarcinomas: case reports from phase 1/2 studies using tin ethyl etiopurpurin (SnET2).
Kaplan MJ; Somers RG; Greenberg RH; Ackler J
J Surg Oncol; 1998 Feb; 67(2):121-5. PubMed ID: 9486784
[TBL] [Abstract][Full Text] [Related]
55. Pretreatment photosensitizer dosimetry reduces variation in tumor response.
Zhou X; Pogue BW; Chen B; Demidenko E; Joshi R; Hoopes J; Hasan T
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1211-20. PubMed ID: 16504761
[TBL] [Abstract][Full Text] [Related]
56. Optical property measurements establish the feasibility of photodynamic therapy as a minimally invasive intervention for tumors of the kidney.
Baran TM; Wilson JD; Mitra S; Yao JL; Messing EM; Waldman DL; Foster TH
J Biomed Opt; 2012 Sep; 17(9):98002-1. PubMed ID: 23085928
[TBL] [Abstract][Full Text] [Related]
57. Fluorescence detection of a new photosensitizer, PAD-S31, in tumour tissues and its use as a photodynamic treatment for skin tumours in dogs and a cat: a preliminary report.
Tanabe S; Yamaguchi M; Iijima M; Nakajima S; Sakata I; Miyaki S; Takemura T; Furuoka H; Kobayashi Y; Matsui T; Uzuka Y; Sarashina T
Vet J; 2004 May; 167(3):286-93. PubMed ID: 15080878
[TBL] [Abstract][Full Text] [Related]
58. [Photodynamic therapy of bladder cancer. A new option].
Neuhaus J; Schastak S; Berndt M; Walther J; Dietel A; Sieger N; Stolzenburg JU
Urologe A; 2013 Sep; 52(9):1225-32. PubMed ID: 24026059
[TBL] [Abstract][Full Text] [Related]
59. Photodynamic therapy for prostate cancer--a review of current status and future promise.
Moore CM; Pendse D; Emberton M
Nat Clin Pract Urol; 2009 Jan; 6(1):18-30. PubMed ID: 19132003
[TBL] [Abstract][Full Text] [Related]
60. Photodynamic therapy for prostate cancer--an emerging approach for organ-confined disease.
Moore CM; Emberton M; Bown SG
Lasers Surg Med; 2011 Sep; 43(7):768-75. PubMed ID: 22057504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
